unknown
Onsior 40 mg 2x60 tablets

Onsior 40 mg 2x60 tablets

Treatment of pain and inflammation associated with chronic osteoarthritis in dogs.

1007476
€245.95
Tax included
Medicinal product subject to veterinary prescription. (996 Items)
Medicinal product subject to veterinary prescription. (996 Items)
✓ Medicinal product subject to veterinary prescription.
Add to wishlist Added to wishlist
 Calculate Shipping Cost

For the treatment of pain and inflammation associated with chronic osteoarthritis in dogs.

Active substance: Robenacoxib

Robenacoxib is a non-steroidal anti-inflammatory drug (NSAID) in the coxib class. It is a potent and selective inhibitor of the cyclooxygenase 2 (COX-2) enzyme. The enzyme cyclooxygenase (COX) is present in two forms. COX-1 is the constituent form of the enzyme and has protective functions, ie gastrointestinal tract and kidneys. COX-2 is the "inducible" form of the enzyme and is responsible for the production of mediators including PGE2 that induces pain, inflammation or fever.

Posology and route of administration:

For oral administration.

Do not use with food as clinical trials have shown better efficacy for robenacoxib when given without food or at least 30 minutes before or after food.

The tablets are palatable and are taken voluntarily by most dogs. The tablets must not break or divide.

The recommended dose of robenacoxib is 1 mg / kg body weight in a range of 1-2 mg / kg. Administer once a day, at the same time.

The clinical response is usually seen within a week. Treatment should be discontinued if after 10 days there is no apparent clinical improvement.

For long-term treatments, when a clinical response is observed, the dose of the veterinary medicinal product should be adjusted to the lowest effective dose as the degree of pain and inflammation associated with chronic arthritis may vary over time. Regular monitoring by the veterinarian should be done.

Because it is a veterinary medicinal product subject to medical prescription, we request to send it to the email: [email protected]

Top